Washington: The Biden administration has signed a $300 million ($US230 million) deal with Australian firm Ellume to dramatically ramp up the production and distribution of rapid at-home COVID-19 tests in the US.
The deal between Ellume, the Department of Defence and the Department of Health and Human Services includes the purchase of 8.5 million COVID-19 tests that will be distributed across America.
In December Ellume became the first company to win approval from US regulators to sell rapid at-home COVID-19 tests that don’t require a prescription. Read more…..
Chart of the Day
Western Australia Premier Mark McGowan today announced a hotel quarantine security guard has tested positive to COVID-19, breaking the state’s nearly 10-month streak of no community transmission.